Thomas Leonard

Director/Board Member at NUGENEREX IMMUNO-ONCOLOGY, INC.

50 year

Health Technology

Consumer Services

Profile

Thomas Leonard is an Independent Director at NuGenerex Immuno-Oncology, Inc. He previously worked as a Manager-Oncology Northeast Business at Bristol Myers Squibb Co. He holds a graduate degree from New York University and an undergraduate degree from St. John's University.

Thomas Leonard active positions

Companies	Position	Start
NUGENEREX IMMUNO-ONCOLOGY, INC.	Director/Board Member	-

All active positions of Thomas Leonard

Former positions of Thomas Leonard

Companies	Position	End
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-

See the detail of Thomas Leonard's experience

Training of Thomas Leonard

New York University	Graduate Degree
St. John's University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas Leonard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	1
NuGenerex Immuno-Oncology, Inc. NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL.	Health Technology